FDA Approves Ibrance Combo Therapy for Some Male Breast Cancers
News
The U.S. Food and Drug Administration (FDA) has expanded the use of Ibrance (palbociclib) capsules in combination with an aromatase inhibitor or Faslodex (fulvestrant) to men with a subset of advanced ... Read more